Achieving blood pressure targets for prolonged cardiovascular health: a historical perspective

References

• Hay J. A british medical association lecture on the significance of a raised blood pressure. BMJ. 1931;2:43–47.
   PubMedGoogle Scholar
• Friedberg CK. Diseases of the Heart. Philadelphia: WB Saunders Co; 1949.
   Google Scholar
• Veterans Administration Cooperative Study Group. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA. 1967;202:1028–1034.
   PubMed Web of Science ®Google Scholar
• Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension, II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA. 1970;213:1143–1152.
   PubMed Web of Science ®Google Scholar
• Moser M. From JNC 1 to JNC 7-What have we learned ? Prog Cardiovasc Dis. 2006;48:303–315.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension. 2003;42:1206–1252.
   PubMed Web of Science ®Google Scholar
• Rsendorff C, Black HR, Cannon CP, et al. Treatment of hypertension in the prevention and management of ischemic heart disease. A scientific statement from the American Heart Association Council on high blood pressure research and the councils on Clinical Cardiology and Epidemiology and Prevention. Circulation. 2007;115:2761–2788.
   PubMed Web of Science ®Google Scholar
• James PA, Oparil S, Carter BL, et al. 2014 evidence-based guidelines for the management of high blood pressure in adults. Report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA. 2015;311:507–520.
   Web of Science ®Google Scholar
• Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood pressure control (SPRINT). N Engl J Med. 2015;373:2103–2116.
   PubMed Web of Science ®Google Scholar
• Chrysant SG, Chrysant GS. The age-related hemodynamic changes of blood pressure and their impact on the incidence of cardiovascular disease and stroke: new evidence. J Clin Hypertens. 2014;16:87–90.
   Web of Science ®Google Scholar
• Roman MJ, Devereux RB, Kizer JR, et al. Central pressure more strongly relates to vascular disease outcome than does brachial pressure. The Strong Heart Study. Hypertension. 2007;50:197–203.
   PubMed Web of Science ®Google Scholar
• Palmieri V, Devereux RB, Hollywood J, et al. Association of pulse pressure with cardiovascular outcome independent of left ventricular hypertrophy and systolic dysfunction: the Strong Heart Study. Am J Hypertens. 2006;19:601–607.
   PubMed Web of Science ®Google Scholar
• Williams B, Lindholm LH, Sever P. Systolic blood pressure is all that matters. Lancet. 2008;371:2219–2221.
   PubMed Web of Science ®Google Scholar
• Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. The ACCORD Study Group. N Engl J Med. 2010;362:1575–1585.
   PubMed Web of Science ®Google Scholar
• Rosendorff C, Lackland DT, Alison M, et al. Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association/American College of Cardiology, and American Society of Hypertension. Hypertension. 2015;65:1372–1407.
   PubMed Web of Science ®Google Scholar
• Vidal-Petiot E, Ford I, Greenlaw N, et al. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort. Lancet. 2016;388:2142–2152.
   PubMed Web of Science ®Google Scholar
• Lewington S, Clark R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data from one million adults in 61 prospective studies. Lancet. 2002;360:129–139.
   PubMed Web of Science ®Google Scholar
• Williamson JD, Suplano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥ 75 years. A randomized clinical trial. JAMA. 2016;315:2673–2682.
   PubMed Web of Science ®Google Scholar
• Cooper-Dehoff RM, Cong Y, Handberg E, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010;304:61–68.
   PubMed Web of Science ®Google Scholar
• Mancia G, Schumacher H, Redon J, et al. Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the ongoing telmisartan alone and in combination with ramipril global endpoint trial (ONTARGET). Circulation. 2011;124:1727–1736.
   PubMed Web of Science ®Google Scholar
• Sim JJ, Shi J, Kovesdy CK, et al. Impact of achieved blood pressure on mortality risk and end-stage renal disease among a large, diverse hypertension population. J Am Coll Cardiol. 2014;64:588–597.
   PubMed Web of Science ®Google Scholar
• Chrysant SG, Chrysant GS. Current status of aggressive blood pressure control in diabetic hypertensive subjects. Am J Cardiol. 2011;107:1855–1861.
   Web of Science ®Google Scholar
• Xie X, Atkins E, Lv J, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2015;387:435–443.
   PubMed Web of Science ®Google Scholar
• Emdin CA, Rahimi K, Neal B, et al. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2015;313:603–615.
   PubMed Web of Science ®Google Scholar
• Yano Y, Rakugi H, Bakris GL, et al. On-treatment blood pressure and cardiovascular outcomes in older adults with isolated systolic hypertension. Hypertension. 2017;69:220–227.
   PubMed Web of Science ®Google Scholar
• Martin MG, Kaczorowski J, Dolovich L, et al. Cardiovascular risk in hypertension in relation to achieving blood pressure using automated office blood pressure measurement. Hypertension. 2016;68:866–872.
   PubMed Web of Science ®Google Scholar
• Bellamy RF. Diastolic coronary artery flow relations in the dog. Circ Res. 1978;43:92–101.
   PubMed Web of Science ®Google Scholar
• Polese A, DeCesare N, Montorsi P, et al. Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle. Circulation. 1991;83:845–853.
   PubMed Web of Science ®Google Scholar
• Pepi A, Alimento M, Maltagliati A, et al. Cardiac hypertrophy in hypertension. Repolarization abnormalities elicited by lowering of pressure. Hypertension. 1988;11:84–91.
   PubMed Web of Science ®Google Scholar
• Messerli FH, Mancia G, Conti CR, et al. Dogma disputed: can aggressive lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006;144:884–893.
   PubMed Web of Science ®Google Scholar
• Bangalore S, Messerli FH, Wun CC, et al. J-curve revisited: an analysis of blood-pressure and cardiovascular events in the Treating to New Targets (TNT) trial. Eur Heart J. 2010;31:2897–2908.
   PubMed Web of Science ®Google Scholar
• Chrysant SG, Chrysant GS. Effectiveness of lowering blood pressure to prevent stroke versus to prevent recurrent coronary events. Am J Cardiol. 2010;106:825–829.
   PubMed Web of Science ®Google Scholar
• Banach M, Aronow WS. Blood pressure J-curve: current concepts. Curr Hypertens Rep. 2012;14:556–566.
   PubMed Web of Science ®Google Scholar
• McEvoy JW, Chen Y, Rawlings A, et al. Diastolic blood pressure, subclinical myocardial damage, and cardiac events: implications for blood pressure control. J Am Coll Cardiol. 2016;68:1713–1722.
   PubMed Web of Science ®Google Scholar
• Bhatt DL. Troponin and the J-curve of diastolic blood pressure. When lower is not better. J Am Coll Cardiol. 2016;68:1723–1726.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013;36(Suppl.1):S11- S66.
   PubMed Web of Science ®Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–2219.
   PubMed Web of Science ®Google Scholar
• Bress AP, Tanner RM, Hess R, et al. Geralizability of SPRINT results to the U. S. adult population. J Am Coll Cardiol. 2016;67:463–472.
   PubMed Web of Science ®Google Scholar
• Gu Q, Burt VL, Dillon CF, et al. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension. The National Health and Nutrition Examination Survey 2001 to 2010. Circulation. 2012;126:2105–2114.
   PubMed Web of Science ®Google Scholar
• Zanchetti A, Thomopoulos C, Parati G. Randomized controlled trials of blood pressure lowering in hypertension: a clinical appraisal. Circ Res. 2015;116:1958.
   Web of Science ®Google Scholar
• Etehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–967.
   PubMed Web of Science ®Google Scholar
• Wright JT Jr, Fine LJ, Lackland DT, et al. Evidence supporting a systolic blood pressure goal of less than 150 mmHg in patients aged 60 years or older: a minority view. Ann Intern Med. 2014;160:499–503.
   PubMed Web of Science ®Google Scholar
• Chobanian AV. Hypertension in 2017- what is the right target? JAMA. 2017;317:579–580.
   PubMed Web of Science ®Google Scholar
• Yano Y, Reis JP, Tedla YG, et al. Racial differences in associations of blood pressure components in young adulthood with incident cardiovascular disease by middle age: Coronary Artery Risk Development in Young Adults (CARDIA) study. JAMA. 2017;2:381–389.
   Google Scholar
• Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs- overview and meta-analysis. J Hypertens. 2015;33:195–211.
   PubMed Web of Science ®Google Scholar
• Iadecola C, Yaffe K, Biller J, et al. Impact of hypertension on cognitive function. A scientific statement from the American Heart Association, on behalf of the American Heart Association Council on Hypertension, Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Quality of Care and Outcomes Research, and Stroke Council. Hypertension. 2016;68:e67- e94.
   PubMed Web of Science ®Google Scholar